Roche announced plans to invest 800 million Swiss francs within its global manufacturing network to increase production capabilities for its biologic medicines over the next five years. The investment will be spread across sites in Penzberg (Germany), Basel (Switzerland), as well as Vacaville and Oceanside (USA). Approximately 500 new jobs are expected to be created in conjunction with the facility expansions.
Sartorius Stedim Biotech today made a cash offer to acquire the UK company TAP Biosystems Group...
Roche and the Medicines Patent Pool Sign Agreement to Increase Access to Medicines to Treat CMV infection in HIV-patients, a major cause of BlindnessAugust 5, 2013 1:00 am | by Roche | News | Comments
The Medicines Patent Pool and healthcare company Roche announce an agreement to increase access...
Analyses of protein structure and function depend on the reliable production of pure,...
Harvard Bioscience Inc., a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today reported unaudited financial results for the three and six months ended June 30, 2013.
Thermo Fisher Scientific Showcases Technologies to Improve Accuracy and Productivity in the Clinical LaboratoryJuly 30, 2013 8:31 am | by Thermo Fisher Scientific | News | Comments
Thermo Fisher Scientific Inc. showcased its comprehensive offering of specialty diagnostics products and analytical instruments designed to improve accuracy and productivity in clinical applications. The Thermo Scientific solutions are on display in booth 5140 during the Clinical Lab Expo at the American Association for Clinical Chemistry (AACC) conference.
Life Technologies Corporation announced that it has signed a five-year agreement with the Food and Drug Administration (FDA) to accelerate and advance food safety testing of E. coli and Salmonella, two foodborne contaminants commonly associated with outbreaks and/or recalls.
Life Technologies Corporation announced the expansion of its global food safety portfolio with the worldwide distribution of the RT-qPCR assays for the detection of Norovirus GI and Norovirus GII, Hepatitis A, and the Mengovirus Extraction Control Kit by CEERAM (the European Centre for Expertise and Research on Microbial Agents).
Group sales 5 percent higher at 23.3 billion Swiss francs; Core EPS 12 percent higher at 7.58 Swiss francs; net income rose to 6 billion Swiss francs; Pharmaceuticals sales rose 6 percent due to cancer medicines and Actemra; Diagnostics sales increased 3 percent driven by Professional Diagnostics, offset by decline in Diabetes Care.
Accelrys, Inc. announced it will report financial results for its 2013 second quarter ended June 30, 2013 after the NASDAQ Market closes on Wednesday, July 31, 2013. The Company will conduct a conference call and an audio webcast at 2 p.m. PT (5 p.m. ET) on the same day.
Roche today announced positive results from the phase III CLL11 study. At a pre-planned interim analysis, an independent data monitoring committee determined that the study met its primary endpoint showing that GA101 plus chlorambucil helped people live significantly longer without their disease worsening (progression-free survival; PFS) compared to MabThera/Rituxan plus chlorambucil.
Life Technologies Corporation announced that it has filed a definitive proxy statement with the U.S. Securities and Exchange Commission regarding Thermo Fisher Scientific Inc.'s (NYSE: TMO) pending acquisition of the Company and has set the date for a special meeting of stockholders to approve the transaction.
'Roche Continents' at the Salzburg Festival explores the common ground of creativity in art and science.July 22, 2013 8:30 am | by Roche | News | Comments
For the seventh time, Roche invites 100 students from all over Europe to the Salzburg Festival for the creativity workshop "Roche Continents". During the course of one week, students from the major European academies will discover the common grounds of innovation in arts and science, aided by a varied program of workshops and discussions with scientists and artists.
Roche today announced the global launch (except US) of two new highly sensitive therapeutic drug monitoring tests for the immunosuppressant medicines tacrolimus and cyclosporine. The new Elecsys Tacrolimus and Cyclosporine tests provide healthcare professionals with more accurate and reliable results.
BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory ResearchJune 19, 2013 4:40 pm | News | Comments
BioCision announced the issuance of new patents by the U.S. Patent Office that apply to two of the company's thermo-conductive products developed to standardize sample handling to ensure the consistency of test conditions and accuracy of results in common laboratory procedures.
QIAGEN N.V. announced the acquisition of Ingenuity Systems, Inc., a provider of software solutions to analyze and interpret the biological meaning of genomic data. Ingenuity, a privately-held U.S. company based in California's Silicon Valley, created a curated knowledge system of biomedical information and analysis solutions for the exploration, interpretation, and analysis of complex biological systems.
Analytik Jena AG, based in Jena, Germany has acquired all of the outstanding shares of Upland, California-based UVP, LLC, including its subsidiary, Ultra-Violet Products Ltd., located in Cambridge, UK. UVP is a manufacturer of bioimaging systems for applications in proteomics, genomics, plant and animal sciences.
Thermo Fisher Scientific Inc. has offered to pay about $13.6 billion to buy genetic testing equipment maker Life Technologies in a cash deal that will create a giant company serving research and specialty diagnostics. The Waltham, Mass., company said Monday it has agreed to pay $76 in cash for each share of Life Technologies, which is based in Carlsbad, Calif.
Pittcon 2013 continues to showcase the release of groundbreaking products for a variety of life science applications.
As Pittcon 2013 kicks off this week, companies are unveiling their latest products to the market.
GE Healthcare Life Sciences announced Jane Stout, from the United States, Anushree Balachandran, from Australia and Markus Posch, from the UK, as the winners of the GE Healthcare 2012 Cell Imaging Competition.
Automated liquid handling instruments are essential component for a wide range of high throughput screening laboratories encompassing disciplines such as biochemistry, immunology, molecular biology, medicinal chemistry, and crystallography. Such automated pipetting instruments allow increased throughput and efficiency, eliminating tedium and the potential for error associated with manual pipetting.
FEI announced that Maria Carbajo from the Universidad de Extemadura, Spain, is the winner of the FEI Image Contest for her “Spider Skin” image. Carbajo’s entry shows the texture of the skin of a spider, with a hair root and brochosomes from a leafhopper preyed upon by the spider.
The judges dove Down Under to select an Australian video of freshwater rotifers as First Prize winner in the 2012 Olympus BioScapes Digital Imaging Competition, a forum for showcasing microscope photos and movies of life science subjects.
SeparateIT gels represent a novel gel matrix for DNA electrophoresis. Gel polymers are arranged in a conceptually different way, in accordance with a new theoretical model of gel electrophoresis.
Using ready-to-use ELISA kits from manufacturers is easy and convenient. Sometimes however, home-made ELISA is required because there is no kit available with the right antibodies or the characteristics of the available kits such as their limits of detection are not appropriate.
Using new methods that detect extremely low levels of DNA molecules, researchers investigated the molecular mechanism of action of various commercially available DNA decontamination reagents. They found that when using high concentrations of DNA and short incubation times, none of the conventional reagents destroyed DNA molecules efficiently, despite their corrosive or even toxic properties.